Next, on treating CRC cells with SIRT5 inhibitor 1, a newly synthesized specific human SIRT5 deacylase inhibitor, we found that DNA synthesis was impaired and cell cycle arrest and apoptosis were induced; nucleoside supplementation reversed these effects (Supplementary Fig. 4a–g). Here, SIRT5 is linked to colorectal carcinoma.